Daniel Torres

Taking a Closer Look At Halozyme Therapeutics Inc (HALO) Following Its Recent Trade

Daniel Torres

In a filing, Halozyme Therapeutics Inc revealed its SVP, CHIEF OPERATING OFFICER Caudill Cortney unloaded Company’s shares for reported $0.28 ...

Investing in Amaze Holdings Inc (AMZE): What You Must Know

Daniel Torres

Amaze Holdings Inc’s filing revealed that its Chief Executive Officer Day Aaron acquired Company’s shares for reported $0.1 million on ...

PVH Corp (PVH) receives a Market perform rating from Telsey Advisory Group

Daniel Torres

PVH Corp’s recently made public that its Chief Executive Officer Larsson Stefan acquired Company’s shares for reported $1.0 million on ...

Keeping an Eye on The Baldwin Insurance Group Inc (BWIN) After Insider Trading Activity

Daniel Torres

The Baldwin Insurance Group Inc’s recent filing unveils that its insider Roche James Morgan unloaded Company’s shares for reported $2.42 ...

Examining the Potential Price Growth of CRISPR Therapeutics AG (CRSP)

Daniel Torres

In a filing, CRISPR Therapeutics AG revealed its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $3.46 million ...

Norwegian Cruise Line Holdings Ltd (NCLH) may enjoy gains as insiders got busy in the recent days

Daniel Torres

Norwegian Cruise Line Holdings Ltd’s filing revealed that its SVP & Chief Accounting Officer Ashby Faye L. unloaded Company’s shares ...

Taking a Closer Look At Quanex Building Products Corp (NX) Following Its Recent Trade

Daniel Torres

Quanex Building Products Corp’s recently made public that its OBSERVER SEAT ON BOARD Teleios Capital Partners GmbH unloaded Company’s shares ...

Investing in Akari Therapeutics Plc ADR (AKTX): What You Must Know

Daniel Torres

Akari Therapeutics Plc ADR’s recent filing unveils that its CEO Gaslightwala Abizer acquired Company’s shares for reported $9400.0 on Aug ...

BTIG Research’s latest rating for MXCT stock

Daniel Torres

In a filing, MaxCyte Inc revealed its Director Hemrajani Rekha unloaded Company’s shares for reported $22378.0 on Jun 25 ’25. ...

Robert W. Baird downgrades Quest Diagnostics, Inc (DGX) stock to a Neutral

Daniel Torres

Quest Diagnostics, Inc’s filing revealed that its CEO and President Davis J. E. unloaded Company’s shares for reported $10.59 million ...

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.